We previously reported that the ErbB2 oncoprotein prolongs and amplifies growth factor signalling by impairing ligand-dependent downregulation of hetero-oligomerised epidermal growth factor receptors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results